Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 73

Tala tallies up $110m

Alphabet-backed microfinance app developer Tala secured the series D funding at a reported $750m valuation, with PayPal among the participants.

Aug 22, 2019

Knotel nets $400m at $1bn+ valuation

Mori Trust, Itochu and existing backers Bloomberg Beta and Rocket Internet all invested in workspace operator Knotel, which has now raised $560m to date.

Aug 22, 2019

H2O.ai flows to Ping An in series D

Ping An Global Voyager Fund co-led H2O.ai's $72.5m series D round, bringing its total funding to $147m in support of its open-source AI model development platform.

Aug 21, 2019

Corporate venturing deal net: 12-16 August 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Aug 16, 2019

ShareChat shakes out $100m in funding

Twitter has led a $100m series D round for social media app ShareChat that valued the multilingual social network operator at $650m.

Aug 16, 2019

Lendingkart races to $30m series D

Bertelsmann India Investments has returned to back online lending marketplace Lendingkart as part of a series D round that took its overall equity funding to at least $143m.

Aug 13, 2019

Naspers reaches Meesho in $125m round

Facebook provided $25m for the social commerce marketplace as part of a Naspers-led round that has been set to value it at up to $650m.

Aug 12, 2019

Oric obtains $55m in series D round

Taiho, Memorial Sloan Kettering Cancer Center and Hartford HealthCare contributed to a round that boosted the cancer drug developer's total funding to more than $175m.

Aug 12, 2019

Corporate venturing deal net: 5-9 August 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Aug 9, 2019

China Life buys into Biocytogen in $77m round

The oncology-focused drug developer sourced $77m in the series D round, which was co-led by China Life Healthcare Fund.

Aug 9, 2019

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here